NA
VAXX

NewEdge Advisors’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

NewEdge Advisors’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed -$4 – 4266
2022
Q4 		$4 Buy
+3
New +$5 ﹤0.01% 3872

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

NewEdge Advisors's VAXX Position: Q1 2023 in Review

NewEdge Advisors sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q1 2023, closing a stake of 3 shares — an estimated $4 sold.

NewEdge Advisors first reported a position in VAXX in Q4 2022 and held it in 1 quarter. The position peaked at $4 in Q4 2022. 48 funds tracked by Wall St. Rank hold VAXX as of Q1 2023.

  • NewEdge Advisors reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • NewEdge Advisors sold 3 Vaxxinity, Inc. Class A Common Stock shares in Q1 2023, an estimated $4.
  • NewEdge Advisors first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • NewEdge Advisors's Vaxxinity, Inc. Class A Common Stock position peaked at $4 in Q4 2022.
  • 48 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.